What is RegenPRP®?
RegenPRP: the platelet concentrate prepared with this RegenLab technology provides
an autologous reservoir of growth factors.
Platelets
Platelets are key factors in tissue repair mechanisms1 . They provide essential growth factors, such as FGF, PDGF, TGF-β, EGF, VEGF, IGF, which are involved in stem cell migration, differentiation and proliferation. Platelets also stimulate fibroblasts and endothelial cells to induce the deposition of new extracellular matrix and neovascularization, respectively. The platelets are concentrated from the patient’s own blood.
Plasma
Contains many factors essential for cell survival including nutrients, vitamins, hormones, electrolytes, growth factors (such as IGF and HGF), and proteins. Among the plasma proteins, the molecules vital for the coagulation process and for formation of the fibrin polymer will serve as a scaffold for cell migration and new tissue generation.
Benefits of this technology
TECHNOLOGY ADVANTAGES
Proven role in the healing of tissues, with key roles in cell migration, proliferation and differentiation.
SCIENTIFIC ADVANTAGES OF RegenPRP
Mechanism of action comprises anti-inflammatory activity and activation of cell-signalling cascades.
CELLULAR MATRIX PLATFORM
Mechanism of action comprises anti-inflammatory activity and activation of cell-signalling cascades.
BIOLOGICAL ADVANTAGES
Mechanism of action comprises anti-inflammatory activity and activation of cell-signalling cascades.
Our products
RegenPRP standardized performance
RegenLab® devices use a separating gel technology that separates the plasma and
platelets from the blood cells to produce RegenPRP with a standardized composition:
Blood sample vol per tube
10 ml
PRP vol per tube
5 to 6 ml
Platelet recovery
> 80 %
Red blood cell depletion
> 80 %
Platelet concentration factor (native)
1.6 X
The volume of blood that is drawn using the A-CP-HA tube is 6 ml, allowing the preparation of a final combination of 60% PRP – 40% HA in a volume of around 5 ml.
RegenPRP standardized performance
Our Technologies
The Regen Lab technology is based on the use of a thixotropic gel to separate the blood components. This process is protected by many patents (US8529957, EP2073862, US2014010857). Thixotropy is a physical property of some gels. The gel acts as a mechanical separator of the blood components.
Quality Products
Regen Lab Quality System Management ensures the consist-ency of our products quality in total GMP compliance. Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.
Contact Regenlab
Now is the time to change your patient’s life. Browse ressources and
get connected to treatment that is right for them.
For more information on our products, please contact us by clicking on the button below:
Our Regional offices are
located in
- New York (USA)
- Montréal (Canada)
- Venice (Italy)
- Munich (Germany)
- Paris (France)
- Dubai (U.A.E.)
- Beijing (China)
- and Istanbul (Turkey)